Unknown

Dataset Information

0

The investigation of the binding of 6-mercaptopurine to site I on human serum albumin.


ABSTRACT: 6-Mercaptopurine (6-MP) is one of a large series of purine analogues which has been found active against human leukemias. The equilibrium dialysis, circular dichroism (CD) and molecular docking were employed to study the binding of 6-MP to human serum albumin (HSA). The binding of 6-MP to HSA in the equilibrium dialysis experiment was detected by measuring the displacement of 6-MP by specific markers for site I on HSA, warfarin (RWF), phenylbutazone (PhB) and n-butyl p-aminobenzoate (ABE). It was shown, according to CD data, that binding of 6-MP to HSA leads to alteration of HSA secondary structure. Based on the findings from displacement experiment and molecular docking simulation it was found that 6-MP was located within binding cavity of subdomain IIA and the space occupied by site markers overlapped with that of 6-MP. Displacement of 6-MP by the RWF or PhB was not up the level expected for a competitive mechanism, therefore displacement of 6-MP was rather by non-cooperative than that the direct competition. Instead, in case of the interaction between ABE and 6-MP, when the little enhancement of the binding of ABE by 6-MP was found, the interaction could be via a positively cooperative mechanism.

SUBMITTER: Sochacka J 

PROVIDER: S-EPMC3483484 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

The investigation of the binding of 6-mercaptopurine to site I on human serum albumin.

Sochacka Jolanta J   Baran Wojciech W  

The protein journal 20121201 8


6-Mercaptopurine (6-MP) is one of a large series of purine analogues which has been found active against human leukemias. The equilibrium dialysis, circular dichroism (CD) and molecular docking were employed to study the binding of 6-MP to human serum albumin (HSA). The binding of 6-MP to HSA in the equilibrium dialysis experiment was detected by measuring the displacement of 6-MP by specific markers for site I on HSA, warfarin (RWF), phenylbutazone (PhB) and n-butyl p-aminobenzoate (ABE). It wa  ...[more]

Similar Datasets

| S-EPMC5761360 | biostudies-literature
| S-EPMC3073228 | biostudies-literature
| S-EPMC5762212 | biostudies-literature
| S-EPMC5686859 | biostudies-literature
| S-EPMC7318646 | biostudies-literature
| S-EPMC1186691 | biostudies-literature
| S-EPMC2831644 | biostudies-literature
| S-EPMC5740134 | biostudies-literature
| S-EPMC4683017 | biostudies-literature
| S-EPMC4654954 | biostudies-literature